Safety and Tolerability Study of Intravitreal VEGF-Trap Administration in Patients With Neovascular AMD
Public ClinicalTrials.gov record NCT00320775. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Exploratory Study of the Safety, Tolerability and Biological Effect of Intravitreal Administration of VEGF Trap in Patients With Neovascular Age-Related Macular Degeneration
Study identification
- NCT ID
- NCT00320775
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Regeneron Pharmaceuticals
- Industry
- Enrollment
- 51 participants
Conditions and interventions
Conditions
Interventions
- VEGF Trap Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2005
- Primary completion
- May 31, 2008
- Completion
- Jul 31, 2008
- Last update posted
- Mar 17, 2015
2005 – 2008
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Centers, PC | Tuscon | Arizona | 85704 | — |
| Loma Linda University Health Care | Loma Linda | California | 92354 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Johns Hopkins Hospital School of Medicine | Baltimore | Maryland | 21287 | — |
| Charlotte Eye, Ear, Nose & Throat Asssociates | Charlotte | North Carolina | 28120 | — |
| Dean A. McGee Eye Institute | Oklahoma City | Oklahoma | 73104 | — |
| Retina Diagnostic and Treatment Assoc., LLC | Philadelphia | Pennsylvania | 19107 | — |
| Retina-Vitreous Associates, P.C. | Nashville | Tennessee | 37203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00320775, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 17, 2015 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00320775 live on ClinicalTrials.gov.